We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $127B
1-Year Est. Return 46.06%
This Fund
S&P 500
This Quarter Est. Return
+0.56%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+788.65%
AUM
$100B
AUM Growth
-$9.45B
Cap. Flow
-$5.83B
Cap. Flow %
-5.81%
Top 10 Hldgs %
31.76%
Holding
3,811
New
911
Increased
1,180
Reduced
974
Closed
681

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$4.21B
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$2.87B
3
WMT icon
Walmart Inc
WMT
+$831M
4
AMZN icon
Amazon
AMZN
+$692M
5
LLY icon
Eli Lilly
LLY
+$641M

Sector Composition

Rank Sector Weight
1 Technology 19.57%
2 Consumer Discretionary 11.57%
3 Healthcare 9.79%
4 Financials 6.87%
5 Industrials 5.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASST icon
3151
Strive Inc
ASST
$1.07B
-6,080
Closed -$90K
ATEX icon
3152
Anterix
ATEX
$1.74B
-291,255
Closed -$6.36M
ATKR icon
3153
Atkore
ATKR
$3.17B
-47,051
Closed -$2.98M
ATO icon
3154
Atmos Energy
ATO
$28.7B
-5,026
Closed -$843K
ATOS icon
3155
Atossa Therapeutics
ATOS
$25.5M
-1,871
Closed -$16.6K
ATRA icon
3156
Atara Biotherapeutics
ATRA
$83.1M
-148,632
Closed -$2.69M
ATXS
3157
DELISTED
Astria Therapeutics
ATXS
-405,700
Closed -$5.31M
AU icon
3158
AngloGold Ashanti
AU
$48.1B
-204,705
Closed -$17.5M
AVDL
3159
DELISTED
Avadel Pharmaceuticals
AVDL
-16,686
Closed -$360K
AVEM icon
3160
Avantis Emerging Markets Equity ETF
AVEM
$27B
-3,260
Closed -$251K
AVIR icon
3161
Atea Pharmaceuticals
AVIR
$405M
-113,585
Closed -$405K
AVNS
3162
DELISTED
Avanos Medical
AVNS
-68,109
Closed -$765K
AVY icon
3163
Avery Dennison
AVY
$13.6B
-2,429
Closed -$442K
AVUV icon
3164
Avantis US Small Cap Value ETF
AVUV
$31B
-6,371
Closed -$650K
BAM icon
3165
Brookfield Asset Management
BAM
$87.1B
-11,638
Closed -$610K
BANF icon
3166
BancFirst
BANF
$3.84B
-22,934
Closed -$2.43M
BB icon
3167
BlackBerry
BB
$5.27B
-5,814,922
Closed -$22M
BBDC icon
3168
Barings BDC
BBDC
$987M
-70,081
Closed -$643K
BCAL icon
3169
Southern California Bancorp
BCAL
$699M
-219,196
Closed -$4.09M
BCC icon
3170
Boise Cascade
BCC
$2.94B
-15,800
Closed -$1.16M
BCBP icon
3171
BCB Bancorp
BCBP
$161M
-27,201
Closed -$220K
BCE icon
3172
BCE
BCE
$21.6B
-332,278
Closed -$7.91M
BDX icon
3173
PUT
Becton Dickinson
BDX
$50B
-300
Closed -$58.2K
BFST icon
3174
Business First Bancshares
BFST
$1.05B
-36,930
Closed -$965K
BGC icon
3175
BGC Group
BGC
$5.12B
-23,030
Closed -$206K

Similar funds

Marshall Wace's Q1 2026 Portfolio in Review

As of Q1 2026, Marshall Wace held 3,811 positions worth $100B, down 8.6% from $110B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Marshall Wace withdrew a net $5.83B in Q1 2026, closing 681 positions and reducing 974 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $2.87B position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Marshall Wace opened a new position in State Street SPDR Portfolio S&P 500 ETF worth $3.8B.

  • Marshall Wace's largest Q1 2026 buy was State Street SPDR Portfolio S&P 500 ETF: 49,650,246 shares worth $3.8B.
  • Marshall Wace added most to Chevron in Q1 2026, an estimated $527M increase.
  • Marshall Wace's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $4.21B.
  • Marshall Wace fully exited Vanguard S&P 500 ETF in Q1 2026, selling an estimated $2.87B.
  • Marshall Wace's ten largest holdings make up 32% of its $100B portfolio in Q1 2026.
  • Marshall Wace opened 911 new positions and closed 681 in Q1 2026.
  • Marshall Wace's portfolio value fell 8.6% quarter-over-quarter to $100B.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.